INOVIO Pharmaceuticals, Inc.

INOVIO Announces Pricing of Approximately $75 Million Public Offering

INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect…